Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease gan Bahez Gareb, Antonius T. Otten, Henderik W. Frijlink, Gerard Dijkstra, Jos G. W. Kosterink

Cael y testun llawn

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams gan Jan-Willem C. Alffenaar, Arianna D. Pranger, Mathieu S. Bolhuis, Jos G. W. Kosterink, Prashant N. Panday

Cael y testun llawn

Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review gan Nanno Schreuder, Iris de Romijn, Pieter L. Jager, Jos G. W. Kosterink, Eugène P. van Puijenbroek

Cael y testun llawn

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process gan Bahez Gareb, Silke Posthumus, Max Beugeling, Pauline Koopmans, Daan J. Touw, Gerard Dijkstra, Jos G.W. Kosterink, Henderik W. Frijlink

Cael y testun llawn

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting. gan Natasha Van't Boveneind-Vrubleuskaya, Alper Daskapan, Jos G W Kosterink, Tjip S van der Werf, Susan van den Hof, Jan-Willem C Alffenaar

Cael y testun llawn

Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples gan Lisanne M. Geers, Dan Cohen, Laura M. Wehkamp, Hans J. van Wattum, Jos G.W. Kosterink, Anton J.M. Loonen, Daan J. Touw

Cael y testun llawn

Pharmacometabolomics may be the next stamp in the pharmacogenetic passport gan Frank Klont, Marieke A.J. Hof, Fleur B. Nijdam, Daan J. Touw, Stephan J.L. Bakker, Gérard Hopfgartner, Jos G.W. Kosterink, Eelko Hak

Cael y testun llawn

Capsules with Ileocolonic-Targeted Release of Vitamin B₂, B₃, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Produ... gan Aisha A. Ahmed, Antonius T. Otten, Bahez Gareb, Judith E. Huijmans, Anko C. Eissens, Ateequr Rehman, Gerard Dijkstra, Jos G. W. Kosterink, Henderik W. Frijlink, Reinout C. A. Schellekens

Cael y testun llawn

Monoclonal antibody biosimilars for cancer treatment gan Linda N. Broer, Daan G. Knapen, Derk-Jan A. de Groot, Peter G.M. Mol, Jos G.W. Kosterink, Elisabeth G.E. de Vries, Marjolijn N. Lub-de Hooge

Cael y testun llawn

Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets. gan Jacoba M Maurer, Reinout C A Schellekens, Hèlen M van Rieke, Christoph Wanke, Ventzeslav Iordanov, Frans Stellaard, Klaus D Wutzke, Gerard Dijkstra, Margot van der Zee, Herman J Woerdenbag, Henderik W Frijlink, Jos G W Kosterink

Cael y testun llawn

Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer. gan Wouter Bult, Stephanie G C Kroeze, Mattijs Elschot, Peter R Seevinck, Freek J Beekman, Hugo W A M de Jong, Donald R A Uges, Jos G W Kosterink, Peter R Luijten, Wim E Hennink, Alfred D van het Schip, J L H Ruud Bosch, J Frank W Nijsen, Judith J M Jans

Cael y testun llawn